copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Our leaders | Edwards Lifesciences Bernard J Zovighian is CEO and on the Board of Directors of Edwards Lifesciences since May 2023, after serving as the company’s president As CEO, Zovighian is leading Edwards into a new era of groundbreaking structural heart innovation, with a sharpened focus and pursuit of expanded opportunities to transform the care of structural heart patients worldwide Building from Edwards
Hemodynamic Monitoring | Edwards Lifesciences All-in-one monitoring is smarter than ever As the hemodynamic monitoring platform that offers full-range cuff, sensor, and catheter compatibility and first-of-its-kind predictive decision support software, HemoSphere monitor enables proactive, individualized patient management
Transcatheter SAPIEN 3 Ultra RESILIA | Edwards Lifesciences Edwards SAPIEN 3, Edwards SAPIEN 3 Ultra, and Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve System Indications: The Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve system is indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a
Who we are - Edwards Lifesciences Through our actions, we will become trusted partners with customers, colleagues, and patients — creating a community unified in its mission to improve the quality of life around the world Our results will benefit customers, patients, employees, and shareholders We will celebrate our successes, thrive on discovery, and continually expand our boundaries We will act boldly, decisively, and
Newsroom - Edwards Lifesciences Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most
Locations - Edwards Lifesciences Headquartered in Irvine, California, our teams work together to create a sense of community and are focused on supporting what is best for Edwards and the patient Interested in a position at Edwards Lifesciences? We have opportunities around the world See where a career with Edwards could take you
Edwards Lifesciences Completes Sale of Critical Care IRVINE, Calif -- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX) for $4 2 billion in an all-cash transaction The net proceeds from the sale will be used to fund strategic initiatives including the previously announced acquisitions and share repurchases “Critical Care
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic . . . IRVINE, Calif -- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) announced today that the U S Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy, the SAPIEN 3 platform, for severe aortic stenosis (AS) patients without symptoms, marking the first FDA approval for TAVR in asymptomatic patients Approval of the SAPIEN 3 platform (SAPIEN 3